Bayer AG (BAYRY)
7.08
+0.04
(+0.57%)
USD |
OTCM |
Apr 19, 16:14
Bayer Free Cash Flow (Quarterly): 5.006B for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.006B |
| September 30, 2023 | 2.068B |
| June 30, 2023 | -198.89M |
| March 31, 2023 | -4.313B |
| December 31, 2022 | 1.945B |
| September 30, 2022 | 1.915B |
| June 30, 2022 | 1.716B |
| March 31, 2022 | -1.206B |
| December 31, 2021 | 2.257B |
| September 30, 2021 | 2.591B |
| June 30, 2021 | 1.812B |
| March 31, 2021 | -3.728B |
| December 31, 2020 | -234.08M |
| September 30, 2020 | 1.741B |
| June 30, 2020 | 2.016B |
| March 31, 2020 | -684.20M |
| December 31, 2019 | 2.464B |
| September 30, 2019 | 1.706B |
| June 30, 2019 | 1.274B |
| March 31, 2019 | 776.98M |
| December 31, 2018 | 2.238B |
| September 30, 2018 | 1.553B |
| June 30, 2018 | 2.116B |
| March 31, 2018 | 379.60M |
| December 31, 2017 | 1.340B |
| Date | Value |
|---|---|
| September 30, 2017 | 2.703B |
| June 30, 2017 | 2.036B |
| March 31, 2017 | 453.81M |
| December 31, 2016 | 1.906B |
| September 30, 2016 | 2.643B |
| June 30, 2016 | 1.599B |
| March 31, 2016 | 1.058B |
| December 31, 2015 | 1.061B |
| September 30, 2015 | 1.872B |
| June 30, 2015 | 1.492B |
| March 31, 2015 | 427.63M |
| December 31, 2014 | 1.727B |
| September 30, 2014 | 1.642B |
| June 30, 2014 | 1.470B |
| March 31, 2014 | -265.78M |
| December 31, 2013 | 1.073B |
| September 30, 2013 | 1.628B |
| June 30, 2013 | 1.351B |
| March 31, 2013 | -50.17M |
| December 31, 2012 | 295.98M |
| September 30, 2012 | 1.844B |
| June 30, 2012 | 1.229B |
| March 31, 2012 | -24.91M |
| December 31, 2011 | 537.89M |
| September 30, 2011 | 1.679B |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-4.313B
Minimum
Mar 2023
5.006B
Maximum
Dec 2023
955.03M
Average
1.741B
Median
Sep 2020
Free Cash Flow (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 776.20M |
| Affimed NV | -27.55M |
| InflaRx NV | -11.65M |
| MorphoSys AG | -- |
| BioNTech SE | 690.54M |